A Multicenter Extension Study to Determine the Long-Term Safety and Efficacy of BG00012 in Pediatric Subjects With Relapsing-Remitting Multiple Sclerosis
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 02 Jun 2017
At a glance
- Drugs Dimethyl fumarate (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- Sponsors Biogen
- 11 Oct 2016 Status changed from recruiting to active, no longer recruiting.
- 02 May 2016 Status changed from not yet recruiting to recruiting.
- 23 Sep 2015 New trial record